Abstract:BACKGROUND:Emerging evidence indicates the importance of heparan sulfate 6-O-sulfotransferase 2 (HS6ST2) in a number of developmental processes. Little is known regarding its biological function in regulating cervical cancer (CC) progression. In this study, we aim to explore the role of HS6ST2 in CC progression.METHODS:The transcriptome sequencing data of CC tissues from three databases, GSE64217, GSE138080, and GSE63514, was examined for genes with significant changes. The expression profile for HS6ST2 within CC tissue was then assessed through fluorescence quantitative PCR and immunohistochemistry and compared to data from patients with clinicopathological features. A multivariate survival analysis was performed using the COX regression. The real-time quantitative PCR assessed the HS6ST2 expression profile within CC cellular cultures. The results of knocking down HS6ST2, considering the proliferative activity and invasiveness of CC cultures in vitro, were detected through cell viability assay, clonogenic assessment, tumorsphere formation analysis, 3D invasion experiment and transwell assay. The impact of HS6ST2 knockdown in CC proliferation was also evaluated in vivo using a nude mice model.RESULTS:HS6ST2 was severely upregulated within CC tissues across the three explored databases (GSE64217, GSE138080, and GSE63514). Fluorescent quantitative PCR and immunohistochemistry experiments identified HS6ST2 as highly upregulated within patients CC tissues. Survival analysis taking into account the parameters of lymph node metastasis, Federation of Gynecology and Obstetrics (FIGO) stage, depth of invasion, pathological grade, and HS6ST2 expression level demonstrated that individuals with downregulated HS6ST2 exhibited considerably extended progression-free survival (PFS) and overall survival (OS) in comparison to upregulated HS6ST2 cases. According to the findings of COX univariate analysis, the parameters lymph node metastasis, FIGO stage, depth of invasion, pathological grade, and HS6ST2 expression level, all showed a statistically significant correlation with effect upon prognosis of CC patients. The FIGO stage, depth of invasion and expression level of HS6ST2 were identified as independent risk variables influencing CC case prognosis within subsequent COX multivariate analysis. Cell function experiments proved that HS6ST2 knockdown can considerably diminish the proliferative potential, stemness and invasive traits of CC cells. Tumor formation experiments in nude mice in vivo demonstrated that knocking down HS6ST2 can significantly thwart CC cellular proliferative properties within animal models.CONCLUSIONS:The clinicopathological features and the survival time of the patients significantly correlate with the level of HS6ST2 expression in CC tissue samples.

ST6GAL2 Downregulation Inhibits Cell Adhesion and Invasion and is Associated with Improved Patient Survival in Breast Cancer.

Gene expression analyses identify a relationship between stanniocalcin 2 and the malignant behavior of colorectal cancer.

The β-galactoside α2,6-sialyltranferase 1 (ST6GAL1) inhibits the colorectal cancer metastasis by stabilizing intercellular adhesion molecule-1 via sialylation.

ST6GALNAC4 Promotes Hepatocellular Carcinogenesis by Inducing Abnormal Glycosylation.

ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface

Differential Expression of ST6GAL1 in the Tumor Progression of Colorectal Cancer.

Loss of ST3GAL4 Exhibits an Anticancer Effect in Breast Cancer Via the Glycolysis Pathway

ST6Gal-I Regulates Human Choriocarcinoma JAR Cells Migration via Up-regulating α2,6-sialylation of Integrin β1

Increasing HER2 Α2,6 Sialylation Facilitates Gastric Cancer Progression and Resistance Via the Akt and ERK Pathways

Gal3ST-2 involved in tumor metastasis process by regulation of adhesion ability to selectins and expression of integrins.

ST3GAL4 promotes tumorigenesis in breast cancer by enhancing aerobic glycolysis

Evaluation of ST6Gal1 expression and clinicopathological significance in human glioma

Downregulation of HS6ST2 Inhibits Cervical Cancer Cell Migration and Invasion in Vivo and in Vitro.

ST6Gal-I predicts postoperative clinical outcome for patients with localized clear-cell renal cell carcinoma.

N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease

Downregulation of the Gnt-V Gene Inhibits Metastasis and Invasion of Bgc823 Gastric Cancer Cells

Polypeptide N -acetylgalactosaminyltransferase-6 expression in gastric cancer.

Knockdown of ST6Gal-I inhibits the growth and invasion of osteosarcoma MG-63 cells

ST6Gal-I modulates docetaxel sensitivity in human hepatocarcinoma cells via the p38 MAPK/caspase pathway

Prognostic Significance of ST6GalNAc-1 Expression in Patients with Non-Metastatic Clear Cell Renal Cell Carcinoma.

Role of the ST6GAL1 sialyltransferase in regulating ovarian cancer cell metabolism